Biomarin Pharmaceutical Inc(BMRN)
106.61
Change: -3.00 (▼ -2.81%)
As of Tue 12/20/2022 09:00 AM% Of Value
Growth
Value Per Share
:
:
:
2997.27
-0.76
0.9500 (as of 19/12/2022)
Fundamentals Data
| Open | 108.63 | Dividend | 166 |
| Close Price | 106.61 | DivYield | 0 % |
| High | 108.63 | Growth | -14.1 M |
| Low | 105.81 | Growth% | -0.76 |
| P/e | -216.627 | Volume | 1.2 M |
| P/b | -3.29 | Market Capital | 19.3 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 92.43 (as of 20/12/2022) | 50 Days Moving Average Percentage | 14.900837860234 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 1.3 B | 1.4 B | 1.7 B | 1.8 B | 1.8 B |
| Cap Spending | -199.2 M | -144.6 M | -145.0 M | -47.1 M | -95.5 M |
| Operating Expenses | 1.0 B | 1.2 B | 1.4 B | 1.3 B | 1.4 B |
| Operating Cash Flow | -14.7 M | -123.5 M | -100.4 M | -36.7 M | -82.3 M |
| Free Cash Flow | -207.9 M | -124.4 M | -96.7 M | 38.2 M | 208.9 M |
| Free Cash Flow Per Share | -1.192 | -0.703 | -0.54 | 0.211 | 1.143 |
| Total liabilities | 1.1 B | 830.4 M | 848.1 M | 1.0 B | 1.0 B |
| Total cash | 598.0 M | 493.9 M | 437.4 M | 649.1 M | 587.2 M |
| ROE% | -0.042 | -0.027 | -0.008 | 0.235 | -0.015 |
| Outstanding Shares | 176.0 M | 178.3 M | 179.9 M | 181.8 M | 184.0 M |
| P/E | -126.426 | -215.448 | -677.663 | 16.388 | -224.009 |
| P/S | 11.264 | 11.155 | 9.484 | 7.568 | 7.775 |
| Revenue USD | 1.3 B | 1.4 B | 1.7 B | 1.8 B | 1.8 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|